Ibarani, Jenilyn .

HRN: 16-50-64  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/27/2025
CEFUROXIME 750MG (VIAL)
12/27/2025
12/28/2025
IV
750 Mg
Every 8 Hours
S/P NSVD With Inc Wbc
Checking Initial Appropriateness 
12/27/2025
CEFUROXIME 500MG (TAB)
12/27/2025
01/02/2026
PO
500 Mg
BID
S/P NSVD With Inc Wbc
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: